Main Session: New Drugs and Novel Mechanisms of Action in Treating Patients with Multiple Myeloma

What are the toxicities associated with the agents used for multiple myeloma?

Charise Gleason, MSN, NP-BC, AOCNP
The Winship Cancer Institute of Emory University

Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here